SECTOR:

SanReno Therapeutics

FUND/VEHICLE:

Pivotal China

INVESTMENT DATE:

2021

GEOGRAPHY:

Asia Pacific

STATUS CURRENT/FORMER INVESTMENT:

Existing

WEBSITE:

SanReno Therapeutics, a China-based company that will develop, manufacture and commercialize kidney disease therapies for the Asian market.